')

Burkhard Feurstein Burkhard Feurstein (CEO)

Burkhard Feurstein has a basic education in Theoretical Physics and specialized in investment and project finance. He has operative experience in manufacturing and as an independent consultant.

Burkhard is partner of GCP gamma capital partners, a Vienna-based Venture Capital Management firm, where he focuses on investment and business development in Life Science companies.

He works with ORIDIS since the first investment of GCP in 2004 and took over the executive role in May 2012.

Marcus Otte Marcus Otte, PhD (CSO)

Biochemist by training with over 15 years of Research and Development experience in drug and biomarker discovery as well as in clinical assay development. He conducted succesfully several studies for clinical biomarker development.

Before joining ORIDIS Biomarkers, he held positions in R&D at Switch Biotech and ORIDIS Biomed.